Sollis can now offer Monoclonal Antibody Therapy for Covid-19 positive patients that meet specific medical criteria as defined in the FDA EUA for the medication. The medical criteria includes mild to moderate COVID symptoms within the first 5 days of symptoms + age over 55 with specific medical problems or age over 65. The Monoclonal Antibody Therapy is only available to patients in a house call setting in the State of New York and California. For patients that we cannot accommodate in NY, we can always refer 7 days a week to the Mount Sinai Antibody Therapy Program as we do currently for all NY antibody referrals.